1. Home
  2. MBIO vs BREA Comparison

MBIO vs BREA Comparison

Compare MBIO & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • BREA
  • Stock Information
  • Founded
  • MBIO 2015
  • BREA 2022
  • Country
  • MBIO United States
  • BREA Ireland
  • Employees
  • MBIO N/A
  • BREA N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • MBIO Health Care
  • BREA Consumer Discretionary
  • Exchange
  • MBIO Nasdaq
  • BREA Nasdaq
  • Market Cap
  • MBIO 7.3M
  • BREA 8.7M
  • IPO Year
  • MBIO N/A
  • BREA 2023
  • Fundamental
  • Price
  • MBIO $2.80
  • BREA $0.63
  • Analyst Decision
  • MBIO Strong Buy
  • BREA
  • Analyst Count
  • MBIO 1
  • BREA 0
  • Target Price
  • MBIO $100.00
  • BREA N/A
  • AVG Volume (30 Days)
  • MBIO 405.3K
  • BREA 39.6K
  • Earning Date
  • MBIO 03-10-2025
  • BREA 01-03-2025
  • Dividend Yield
  • MBIO N/A
  • BREA N/A
  • EPS Growth
  • MBIO N/A
  • BREA N/A
  • EPS
  • MBIO N/A
  • BREA N/A
  • Revenue
  • MBIO N/A
  • BREA $2,872,101.00
  • Revenue This Year
  • MBIO N/A
  • BREA N/A
  • Revenue Next Year
  • MBIO N/A
  • BREA N/A
  • P/E Ratio
  • MBIO N/A
  • BREA N/A
  • Revenue Growth
  • MBIO N/A
  • BREA 2338.69
  • 52 Week Low
  • MBIO $2.40
  • BREA $0.50
  • 52 Week High
  • MBIO $74.50
  • BREA $2.44
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.74
  • BREA 38.35
  • Support Level
  • MBIO $2.40
  • BREA $0.60
  • Resistance Level
  • MBIO $3.04
  • BREA $0.67
  • Average True Range (ATR)
  • MBIO 0.65
  • BREA 0.04
  • MACD
  • MBIO 0.06
  • BREA -0.01
  • Stochastic Oscillator
  • MBIO 9.30
  • BREA 13.91

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: